Walleye Trading’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.2K | Buy |
+761
| New | +$13.2K | ﹤0.01% | 875 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 975 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1094 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1246 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1499 |
|
|
2024
Q1 | – | Sell |
-12,831
| Closed | -$768K | – | 1643 |
|
|
2023
Q4 | $768K | Sell |
12,831
-12,649
| -50% | -$757K | ﹤0.01% | 672 |
|
|
2023
Q3 | $969K | Buy |
25,480
+18,484
| +264% | +$703K | ﹤0.01% | 519 |
|
|
2023
Q2 | $637K | Sell |
6,996
-3,728
| -35% | -$340K | ﹤0.01% | 468 |
|
|
2023
Q1 | $707K | Buy |
+10,724
| New | +$707K | ﹤0.01% | 467 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1716 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1862 |
|
|
2022
Q2 | – | Sell |
-518
| Closed | -$26K | – | 1910 |
|
|
2022
Q1 | $26K | Buy |
+518
| New | +$26K | ﹤0.01% | 1522 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1984 |
|
|
2021
Q3 | – | Sell |
-10,396
| Closed | -$657K | – | 1739 |
|
|
2021
Q2 | $657K | Buy |
+10,396
| New | +$657K | ﹤0.01% | 575 |
|
|
2020
Q3 | – | Sell |
-5,025
| Closed | -$164K | – | 1072 |
|
|
2020
Q2 | $164K | Buy |
5,025
+4,017
| +399% | +$131K | ﹤0.01% | 728 |
|
|
2020
Q1 | $27K | Buy |
+1,008
| New | +$27K | ﹤0.01% | 971 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 1285 |
|